What Savara Investors Should Know About 580K Options
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesSavara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Joby Aviation just crossed a major regulatory milestone, but what does that mean for investors? This in-depth guide b...
Sam Altman raised questions about SpaceX's bold plan for AI data centers in space. This article breaks down the viabi...
ANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...
Intel faces renewed pressure as AMD gains share in the server CPU market, driven by AI workloads. This guide explains...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
The National Taxpayer Advocate says tens millions taxpayers owed refunds or relief may be available due to COVID-era ...
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Nike has faced a tough run, but a turnaround could be on the horizon. This guide breaks down the factors to watch, re...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
Linked Polymarket accounts reportedly racked up millions on Iran-related bets, prompting questions about insider info...